vs
FEDERAL SIGNAL CORP（FSS）与Sarepta Therapeutics, Inc.（SRPT）财务数据对比。点击上方公司名可切换其他公司
FEDERAL SIGNAL CORP的季度营收约是Sarepta Therapeutics, Inc.的1.6倍（$597.1M vs $369.6M），FEDERAL SIGNAL CORP净利率更高（10.2% vs -111.5%，领先121.7%），FEDERAL SIGNAL CORP同比增速更快（26.5% vs -42.1%），Sarepta Therapeutics, Inc.自由现金流更多（$127.6M vs $89.5M），过去两年FEDERAL SIGNAL CORP的营收复合增速更高（18.5% vs 1.4%）
联邦信号公司是20世纪早期的美国企业，主营铁路信号设备的制造业务，总部坐落于美国纽约州奥尔巴尼市，其生产的相关信号产品在当时的美国轨道交通行业得到了广泛应用，具备一定的行业知名度。
Sarepta Therapeutics是一家总部位于美国马萨诸塞州剑桥的生物医药企业，专注于医学研究与药物研发。公司成立于1980年，前身为AntiVirals，后续先后更名为AVI BioPharma及现名，截至2023年已有四款获批上市药物，在相关疾病治疗领域深耕技术创新。
FSS vs SRPT — 直观对比
营收规模更大
FSS
是对方的1.6倍
$369.6M
营收增速更快
FSS
高出68.6%
-42.1%
净利率更高
FSS
高出121.7%
-111.5%
自由现金流更多
SRPT
多$38.1M
$89.5M
两年增速更快
FSS
近两年复合增速
1.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $597.1M | $369.6M |
| 净利润 | $60.8M | $-412.2M |
| 毛利率 | 28.4% | — |
| 营业利润率 | 14.0% | -111.4% |
| 净利率 | 10.2% | -111.5% |
| 营收同比 | 26.5% | -42.1% |
| 净利润同比 | 21.6% | -359.2% |
| 每股收益（稀释后） | $0.99 | $-3.92 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSSSRPT
| Q4 25 | $597.1M | $369.6M | ||
| Q3 25 | $555.0M | $370.0M | ||
| Q2 25 | $564.6M | $513.1M | ||
| Q1 25 | $463.8M | $611.5M | ||
| Q4 24 | $472.0M | $638.2M | ||
| Q3 24 | $474.2M | $429.8M | ||
| Q2 24 | $490.4M | $360.5M | ||
| Q1 24 | $424.9M | $359.5M |
净利润FSSSRPT
| Q4 25 | $60.8M | $-412.2M | ||
| Q3 25 | $68.1M | $-50.6M | ||
| Q2 25 | $71.4M | $196.9M | ||
| Q1 25 | $46.3M | $-447.5M | ||
| Q4 24 | $50.0M | $159.0M | ||
| Q3 24 | $53.9M | $33.6M | ||
| Q2 24 | $60.8M | $6.5M | ||
| Q1 24 | $51.6M | $36.1M |
毛利率FSSSRPT
| Q4 25 | 28.4% | — | ||
| Q3 25 | 29.1% | 59.3% | ||
| Q2 25 | 30.0% | 70.3% | ||
| Q1 25 | 28.2% | 77.5% | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | 29.6% | 78.7% | ||
| Q2 24 | 29.4% | 87.6% | ||
| Q1 24 | 27.3% | 85.9% |
营业利润率FSSSRPT
| Q4 25 | 14.0% | -111.4% | ||
| Q3 25 | 16.9% | -27.9% | ||
| Q2 25 | 17.3% | 22.5% | ||
| Q1 25 | 14.2% | -49.1% | ||
| Q4 24 | 14.9% | 25.3% | ||
| Q3 24 | 16.0% | 5.2% | ||
| Q2 24 | 16.5% | -0.2% | ||
| Q1 24 | 12.8% | 9.7% |
净利率FSSSRPT
| Q4 25 | 10.2% | -111.5% | ||
| Q3 25 | 12.3% | -13.7% | ||
| Q2 25 | 12.6% | 38.4% | ||
| Q1 25 | 10.0% | -73.2% | ||
| Q4 24 | 10.6% | 24.9% | ||
| Q3 24 | 11.4% | 7.8% | ||
| Q2 24 | 12.4% | 1.8% | ||
| Q1 24 | 12.1% | 10.0% |
每股收益（稀释后）FSSSRPT
| Q4 25 | $0.99 | $-3.92 | ||
| Q3 25 | $1.11 | $-0.50 | ||
| Q2 25 | $1.16 | $1.89 | ||
| Q1 25 | $0.75 | $-4.60 | ||
| Q4 24 | $0.80 | $1.56 | ||
| Q3 24 | $0.87 | $0.34 | ||
| Q2 24 | $0.99 | $0.07 | ||
| Q1 24 | $0.84 | $0.37 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $63.7M | $939.6M |
| 总债务越低越好 | $564.6M | $829.0M |
| 股东权益账面价值 | $1.4B | $1.1B |
| 总资产 | $2.4B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.41× | 0.73× |
8季度趋势，按日历期对齐
现金及短期投资FSSSRPT
| Q4 25 | $63.7M | $939.6M | ||
| Q3 25 | $54.4M | $851.0M | ||
| Q2 25 | $64.7M | $800.1M | ||
| Q1 25 | $57.5M | $522.8M | ||
| Q4 24 | $91.1M | $1.4B | ||
| Q3 24 | $73.7M | $1.2B | ||
| Q2 24 | $48.6M | $1.5B | ||
| Q1 24 | $48.9M | $1.4B |
总债务FSSSRPT
| Q4 25 | $564.6M | $829.0M | ||
| Q3 25 | $201.2M | $140.5M | ||
| Q2 25 | $258.3M | — | ||
| Q1 25 | $266.9M | — | ||
| Q4 24 | $204.4M | $1.1B | ||
| Q3 24 | $223.3M | $1.2B | ||
| Q2 24 | $248.8M | $1.2B | ||
| Q1 24 | $266.8M | $1.2B |
股东权益FSSSRPT
| Q4 25 | $1.4B | $1.1B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.3B | $1.4B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.2B | $1.5B | ||
| Q3 24 | $1.1B | $1.2B | ||
| Q2 24 | $1.1B | $1.1B | ||
| Q1 24 | $1.0B | $961.2M |
总资产FSSSRPT
| Q4 25 | $2.4B | $3.3B | ||
| Q3 25 | $1.9B | $3.5B | ||
| Q2 25 | $1.9B | $3.7B | ||
| Q1 25 | $1.9B | $3.5B | ||
| Q4 24 | $1.8B | $4.0B | ||
| Q3 24 | $1.7B | $3.6B | ||
| Q2 24 | $1.7B | $3.4B | ||
| Q1 24 | $1.7B | $3.2B |
负债/权益比FSSSRPT
| Q4 25 | 0.41× | 0.73× | ||
| Q3 25 | 0.15× | 0.11× | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.17× | 0.74× | ||
| Q3 24 | 0.19× | 1.01× | ||
| Q2 24 | 0.23× | 1.14× | ||
| Q1 24 | 0.26× | 1.29× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $97.2M | $131.2M |
| 自由现金流经营现金流 - 资本支出 | $89.5M | $127.6M |
| 自由现金流率自由现金流/营收 | 15.0% | 34.5% |
| 资本支出强度资本支出/营收 | 1.3% | 1.0% |
| 现金转化率经营现金流/净利润 | 1.60× | — |
| 过去12个月自由现金流最近4个季度 | $227.1M | $-307.5M |
8季度趋势，按日历期对齐
经营现金流FSSSRPT
| Q4 25 | $97.2M | $131.2M | ||
| Q3 25 | $61.1M | $-14.6M | ||
| Q2 25 | $59.7M | $261.3M | ||
| Q1 25 | $36.7M | $-583.4M | ||
| Q4 24 | $90.6M | $92.0M | ||
| Q3 24 | $68.8M | $-70.7M | ||
| Q2 24 | $40.6M | $14.9M | ||
| Q1 24 | $31.3M | $-242.1M |
自由现金流FSSSRPT
| Q4 25 | $89.5M | $127.6M | ||
| Q3 25 | $54.1M | $-37.5M | ||
| Q2 25 | $52.4M | $229.5M | ||
| Q1 25 | $31.1M | $-627.1M | ||
| Q4 24 | $82.1M | $54.0M | ||
| Q3 24 | $60.9M | $-108.0M | ||
| Q2 24 | $24.8M | $-14.2M | ||
| Q1 24 | $22.9M | $-274.5M |
自由现金流率FSSSRPT
| Q4 25 | 15.0% | 34.5% | ||
| Q3 25 | 9.7% | -10.1% | ||
| Q2 25 | 9.3% | 44.7% | ||
| Q1 25 | 6.7% | -102.5% | ||
| Q4 24 | 17.4% | 8.5% | ||
| Q3 24 | 12.8% | -25.1% | ||
| Q2 24 | 5.1% | -3.9% | ||
| Q1 24 | 5.4% | -76.4% |
资本支出强度FSSSRPT
| Q4 25 | 1.3% | 1.0% | ||
| Q3 25 | 1.3% | 6.2% | ||
| Q2 25 | 1.3% | 6.2% | ||
| Q1 25 | 1.2% | 7.1% | ||
| Q4 24 | 1.8% | 6.0% | ||
| Q3 24 | 1.7% | 8.7% | ||
| Q2 24 | 3.2% | 8.1% | ||
| Q1 24 | 2.0% | 9.0% |
现金转化率FSSSRPT
| Q4 25 | 1.60× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.84× | 1.33× | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 1.81× | 0.58× | ||
| Q3 24 | 1.28× | -2.10× | ||
| Q2 24 | 0.67× | 2.31× | ||
| Q1 24 | 0.61× | -6.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FSS
| Vehiclesandequipment | $403.4M | 68% |
| Parts | $66.8M | 11% |
| Publicsafetyandsecurityequipment | $62.2M | 10% |
| Rentalincome | $19.0M | 3% |
| Industrialsignalingequipment | $18.2M | 3% |
| Other | $14.9M | 2% |
| Warningsystems | $12.6M | 2% |
SRPT
| Pmo Products | $202.5M | 55% |
| Elevidys | $110.4M | 30% |
| Other | $56.7M | 15% |
